Title : Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.

Pub. Date : 2017 Nov

PMID : 28701571

1 Functional Relationships(s)
Compound Name
Protein Name
1 We evaluated nab-Paclitaxel efficacy as neoadjuvant treatment for early estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) disease. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens